Apollon Wealth Management LLC Has $4.89 Million Stock Position in Danaher Co. (NYSE:DHR)

Apollon Wealth Management LLC lessened its stake in shares of Danaher Co. (NYSE:DHR) by 2.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 21,287 shares of the conglomerate’s stock after selling 628 shares during the period. Apollon Wealth Management LLC’s holdings in Danaher were worth $4,886,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of DHR. Heck Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher in the 4th quarter worth $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher in the 4th quarter worth $31,000. Finally, Teachers Insurance & Annuity Association of America bought a new stake in shares of Danaher in the 3rd quarter worth $39,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of several research reports. Robert W. Baird reduced their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Wells Fargo & Company dropped their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Guggenheim began coverage on shares of Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Finally, Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of DHR opened at $206.92 on Friday. Danaher Co. has a fifty-two week low of $205.79 and a fifty-two week high of $281.70. The firm’s 50-day simple moving average is $232.72 and its two-hundred day simple moving average is $251.79. The stock has a market cap of $149.45 billion, a PE ratio of 39.19, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business earned $2.09 earnings per share. Analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is currently 20.45%.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.